FdaApplication
NDA 209863
Identifiers
- fda_app_no: NDA209863
Properties
| Property | Value |
|---|---|
| applicant_name | ANTARES PHARMA INC |
| application_type | NDA |
| approval_date | 2018-09-28 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | 75MG/0.5ML (75MG/0.5ML) | SOLUTION;SUBCUTANEOUS |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | 100MG/0.5ML (100MG/0.5ML) | SOLUTION;SUBCUTANEOUS |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | 50MG/0.5ML (50MG/0.5ML) | SOLUTION;SUBCUTANEOUS |
3 products